Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer

Hyeongi Kim1,2, Javeria Zaheer1,3, Eui-Ju Choi2

  • 1Division of RI Application, Korea Institute Radiological and Medical Sciences, Seoul 01812, Republic of Korea.

Theranostics
|May 13, 2022
PubMed

Insights

Microplastic (MP) exposure in mice increased gastric cancer stemness and drug resistance, linked to ASGR2. This suggests MPs may promote gastric cancer development and treatment resistance.

Area of Science:

  • Environmental Science
  • Toxicology
  • Oncology

Background:

  • Microplastics (MPs) pose a growing environmental threat.
  • Previous studies tracked MP biodistribution; this study investigates MP effects on gastric cancer.

Purpose of the Study:

  • To determine if polystyrene (PS) microplastic exposure induces malignant effects in the stomach.
  • To assess if PS exposure leads to cancer stemness and therapy resistance in a gastric cancer model.

Main Methods:

  • Mice were exposed to polystyrene microplastics (MPs) via diet.
  • PS accumulation, cancer stemness markers, multidrug resistance, and gene expression (RNA-Seq) were analyzed.
  • A 4-week PS-exposed NCI-N87 gastric cancer mouse model was used for in vivo assessments.

Main Results:

  • PS accumulated in gastric tissues and increased cancer cell migration and N-cadherin expression.
  • PS exposure induced multidrug resistance to various therapies, linked to CD44 upregulation.
  • RNA-Seq identified increased ASGR2 expression, which promoted cancer hallmarks and therapy resistance.

Conclusions:

  • ASGR2 plays a key role in enhancing cancer hallmarks and therapy resistance following microplastic exposure.
  • These findings highlight a potential link between MP exposure and gastric cancer, warranting further epidemiological research.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
646
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
230
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
571
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K